Having problems reading this email or accessing the links?
To view this email in your web browser, click here.
To change your preferred email format or unsubscribe, click here.

Vol. 5, No. 077
Tues., March 23, 2010

Underwriter:

Amgen Oncology

Depend

Resources:

Active Surveillance Is An Option For Many Men With Prostate Cancer

In This Issue:

LEAD

WHAT'S NEW AT ZERO

RESEARCH AND TREATMENT UPDATE

CLASSIFIEDS
 


[Advertisement]

Oncologist Survey


Lead

Active Surveillance Is An Option For Many Men With Prostate Cancer

Active surveillance, also known as watchful waiting, is a viable option for many men with low-risk prostate cancer, though the concept continues to cause distress and confusion, acknowledges chairman of the National Comprehensive Cancer Network's prostate cancer medical guidelines panel.


Infertility Linked to Prostate Cancer

Male infertility may be an early and identifiable risk factor for the future development of aggressive prostate cancer, according to this California study of more than 22,000 men.


Cough Medicine Ingredient May Help Prevent Prostate Cancer

Noscapine, a non-addictive derivative of opium that is used in over-the-counter cough medicine, is shown to greatly reduce prostate cancer in studies involving mice.


Balding Before 30 May Cut Prostate Cancer Risk

New research findings are said to be completely contrary to traditional views regarding baldness and the risk of prostate cancer.


[Advertisement]

Depend


What's New at ZERO

Health Care Reform Puts Access to PSA Test in Jeopardy

On March 21, Democrats passed sweeping healthcare reform legislation that will make health insurance attainable for some 32 million Americans who are currently uninsured.

While the healthcare reform bill was signed into law today by President Obama, many of the reforms will not take effect until 2014, including the highly-controversial mandate for all Americans to carry health insurance.

One of the key features of the legislation, as touted by many Democrats, was to make preventive health care services affordable and available to all Americans. However, many preventive tests - such as the PSA test - may not be covered. This is because the language of the bill only requires insurers to cover preventive services that are graded an "A" or "B" by the U.S. Preventive Services Task Force (USPSTF), a panel of physicians that does not include a single urologist. The PSA test did not receive either of these grades from the USPSTF and will not be required to be covered by insurers.


We Need Your Help to Increase Prostate Cancer Research Funding

Write your U.S. SENATORS NOW! Deadline is March 24.

   
     

ZERO needs your help by communicating to your U.S. Senators to emphasize the importance of increasing funding for prostate cancer research.

Senators Tim Johnson (SD) and Mike Crapo (ID) have circulated a letter to their Senate colleagues asking for their support for increased funding for the Prostate Cancer Research Program (PCRP), which is part of the Congressionally Directed Medical Research Program at the Department of Defense.

The program's funding has been stagnant at around $80 million for nine years.

Because of the extended leveling of the program, grants to continue research into clinical trials have slowed to a halt. Unless Congress acts to increase funding for the PCRP, important research cannot move forward to potentially help patients fight their prostate cancer.


Register for the 2010 'Summit to End Prostate Cancer' in Washington, D.C.

  The Summit  
     

You can make a positive impact this Fall by representing ZERO and the entire prostate cancer community in Washington, D.C. Registration for the 2010 "Summit to End Prostate Cancer" is now open!

This year's 2010 Summit, scheduled for September 14-16, will focus on effective strategies for increasing the Federal investment in prostate cancer research. During the Summit, participants will have the opportunity to meet with their elected officials on Capitol Hill and learn more about the federal legislative process.


Join the Drive Against Prostate Cancer by Supporting 'Pennies for Prostates'

Now is your chance to take command, sit in the driver's seat, and put the 'pedal to the metal' to show your support for the prostate cancer community.

That's what Robin Sparrow plans to do this April, driving his BMW more than 3,000 miles in 12 days as part of the One Lap of America Race - the "real life" Cannonball Run.


'DASH FOR DAD' Race Series Coming to 11 Cities to Raise Prostate Cancer Awareness

As National Race Series Expands Across U.S. in 2010, Supporters Are Encouraged to Bring This Event to Their City

Lace up your sneakers and join us in the race to end prostate cancer!

DASH FOR DAD, the premier prostate cancer race series in the U.S., is a heartfelt tight-knit community event that brings together athletes, cancer survivors, physicians, caregivers, family members and friends. Proceeds from each 10K race are used to provide free prostate cancer testing for men in the local community of the event.

ZERO - The Project to End Prostate Cancer with sponsors from across the country has grown the DASH FOR DAD and its partner races - the Great Prostate Cancer Challenge - to include 11 cities and an expected 5,000 runners competing in 2010.

The DASH FOR DAD or partnering Great Prostate Cancer Challenge 5K will be held in the following cities during September, known as "National Prostate Cancer Awareness Month":

  Dash for Dad  
     
  • Baltimore, MD
  • Buffalo, NY
  • Central FL
  • Columbus, OH
  • Harrisburg, PA
  • Indianapolis, IN
  • Kansas City, MO
  • Long Island, NY
  • Memphis, TN
  • Nashville, TN
  • Washington, DC metro area (Alexandria, VA)

Since the national race series began in 2008, more than $1 million has been raised to promote prostate cancer awareness, early detection and research. Many runners create teams and collect monetary pledges from family and friends to boost funding for local prostate cancer services.

Hosting a DASH FOR DAD is a significant way to promote prostate cancer awareness in your area - and there is still time to bring this race to your city!

Urology medical practices and other supporting organizations are especially encouraged to organize a DASH FOR DAD, due to the importance of providing free prostate cancer testing and promoting research for a cure. Click here to download the DASH FOR DAD race application.

"DASH FOR DAD elevates prostate cancer awareness to a broader nationwide level," said ZERO's CEO Skip Lockwood. "We all know someone who is impacted by this most commonly diagnosed cancer among men, striking one in every six. That's why we must do all that we can to put an end to this horrible disease."

For more information about the DASH FOR DAD 10K or if you're interested in hosting a DASH FOR DAD run to your city, contact Tracy Cesaretti.


Be a Star Athlete -- Register Now to Join ZERO's DASH FOR DAD Team

   
     

Help fight prostate cancer by joining ZERO's DASH FOR DAD Endurance Team!

Even though the teams are now complete for the Nautica New York City Triathlon and the Bank of America Chicago Marathon, you still have time to sign up to be among the runners on the DASH FOR DAD Endurance Team at the Marine Corps Marathon in Washington, D.C. on October 24, or the ING New York City Marathon on November 7.

These race slots go quickly, so please sign up soon!

For more information, contact Tracy Cesaretti at 202-303-3111.

Every dollar raised goes toward free prostate cancer testing for men across the U.S.

ZERO - The Project to End Prostate Cancer provides you with fundraising advice and support, your own donation website and list-serv, and other tools to make your participation in these races highly memorable and successful.


[Advertisement]

MPI


Research and Treatment Update

New Attack on Cancer Forces Cells to Grow Old and Die

Takeda Pharmaceutical's experimental cancer drug MLN4924, now in early-stage clinical trials, appears to be able to block a cancer-causing gene called Skp2 and forces cancer cells to go through an aging process and then die.


Freezing Tumors Shows Promise Against Prostate, Breast Cancer

Successful results are shown when magnetic resonance imaging is used with cryotherapy, a process of freezing and destroying malignant tumors.


Increased Radiation Dose Does Not Increase Long-Term Side Effects for Prostate Cancer Patients, Study Suggests

Researchers also find that patients characterized the impact of continuing side effects on their quality of life as considerably less bothersome than might be expected.


Snacking on Walnuts 'Helps to Prevent Prostate Cancer'

Walnuts, naturally rich in health-boosting chemicals such as omega-3 fatty acids, may help prevent prostate cancer, according to this University of California research.


Classifieds

Advertise in AWARE, ZERO's weekly electronic newsletter, to reach more than 20,000 readers throughout the prostate cancer community in the U.S. and abroad. Contact Jamie Bearse at (202) 303-3105 to learn more about our advertising and partner development opportunities.

da Vinci Surgery Aureon
Cyberknife MPI

PSA Standardization DVDPSA Standardization DVD:
How Your PSA Test Results May be Affected

Brand New! Your PSA score may be 22 percent higher than actual score. There are two different standardizations of PSA tests and the difference in score could mean you have an undetected rising PSA or a false rise in the score. Know the facts, get this DVD about PSA standardization.

Prostate Cancer Action Store

Show your support for the fight against prostate cancer and purchase the latest items, including educational materials and apparel, in ZERO's online store.


Subscription Info

You received this newsletter because your email address () is subscribed to our mailing list.

Forward to a Friend:
To forward this email to a friend, click the link below.

To Subscribe:
Not yet receiving any newsletters from ZERO? Sign up for FREE and get all the latest news on prostate cancer delivered to you.

To Edit Your Profile or Unsubscribe:
If you wish to change your preferred email format, change your profile or to unsubscribe from further emails from ZERO, click the link below.

Advertising Info

Reach thousands with America's largest online newsletter all about prostate cancer.

To Advertise, Contact:
Jamie Bearse
Chief Operating Officer
(202) 303-3105

Contact Info

ZERO - The Project to End Prostate Cancer
10 G Street NE, Suite #601
Washington, DC 20002
Tel: (202) 463-9455
Fax: (202) 463-9456
ZeroCancer.org
info@zerocancer.org

Director of Communications:
Linwood Norman

Creative Director:
Perry C. Cojuangco

Chief Operating Officer:
Jamie Bearse

AWARE is managed in-house by ZERO's communications department.

AWARE is America's premier online, weekly newsletter that brings you information about prostate cancer. It is produced by ZERO - The Project to End Prostate Cancer (ZERO). This publication seeks to inform and educate men and women about prostate cancer. Information presented in this free publication does not necessarily represent the official position of ZERO. As information for AWARE is brought to you from diverse websites and information sources, ZERO cannot guarantee the accuracy of these sources. Due to the timeliness of the information, some links may change or deactivate without notice.

Copyright © 2009 ZERO - The Project to End Prostate Cancer. All Rights Reserved. ZERO does not endorse any course of treatment for men with prostate cancer or other conditions. Treatment decisions should be made by a patient and his health service provider. All names, logos and articles are the copyrights of the respective owners.